A combined model of insulin-like growth factor-binding protein-2 (IGFBP-2), lecithin cholesterol acyltransferase (LCAT), and CA125 outperformed CA125 detection alone for the earlier detection of ovarian cancer in terms of the sensitivity. Here, IGFBP2 is linked to ovarian carcinoma.